Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro
Open Access
- 27 April 2010
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (9), 1361-1370
- https://doi.org/10.1038/sj.bjc.6605656
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- 3,3′,4,4′,5,5′-Hexahydroxystilbene Impairs Melanoma Progression in a Metastatic Mouse ModelJournal of Investigative Dermatology, 2010
- Short 42 C heat shock induces phosphorylation and degradation of Cdc25A which depends on p38MAPK, Chk2 and 14.3.3Human Molecular Genetics, 2009
- The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionMolecular Cancer, 2007
- Cancer Cells Cause Vascular Endothelial Cell (vEC) Retraction via 12(S)HETE Secretion; The Possible Role of Cancer Cell Derived MicroparticleAnnals of Surgical Oncology, 2006
- Methyl gallate and chemicals structurally related to methyl gallate protect human umbilical vein endothelial cells from oxidative stressExperimental & Molecular Medicine, 2005
- p21Cip/WAF1 activation is an important factor for the ERK pathway dependent anti-proliferation of colorectal cancer cellsExperimental & Molecular Medicine, 2004
- Maintenance of ATP favours apoptosis over necrosis triggered by benzamide ribosideCell Death & Differentiation, 2002
- Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration scheduleGene Therapy, 1999
- Resveratrol Arrests the Cell Division Cycle at S/G2 Phase TransitionBiochemical and Biophysical Research Communications, 1998
- Antioxidant, Gallic Acid, Induces Apoptosis in HL-60RG CellsBiochemical and Biophysical Research Communications, 1994